Notable companies
The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), AstraZeneca PLC (NASDAQ:AZN), Amgen (NASDAQ:AMGN), Medtronic plc (NYSE:MDT), Bristol-Myers Squibb Co (NYSE:BMY), Boston Scientific Corp (NYSE:BSX), Regeneron Pharmaceuticals (NASDAQ:REGN), Edwards Lifesciences Corp (NYSE:EW).
Industry description
The investment seeks results that correspond generally to the price and yield performance, before fees and expenses, of the Indxx Aging Population Thematic Index.
The fund invests more than 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies in developed markets that facilitate the demographic trend of longer average life spans and the aging of the global population, including but not limited to companies involved in biotechnology, medical devices, pharmaceuticals, senior living facilities and specialized health care services.
Market Cap
The average market capitalization across the Global X Aging Population ETF ETF is 48.97B. The market cap for tickers in the group ranges from 106.99M to 739.66B. LLY holds the highest valuation in this group at 739.66B. The lowest valued company is ALEC at 106.99M.
High and low price notable news
The average weekly price growth across all stocks in the Global X Aging Population ETF ETF was 24%. For the same ETF, the average monthly price growth was 36%, and the average quarterly price growth was 68%. SN experienced the highest price growth at 28%, while AGL experienced the biggest fall at -39%.
Volume
The average weekly volume growth across all stocks in the Global X Aging Population ETF ETF was -1%. For the same stocks of the ETF, the average monthly volume growth was 9% and the average quarterly volume growth was 15%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 63
P/E Growth Rating: 66
Price Growth Rating: 50
SMR Rating: 63
Profit Risk Rating: 61
Seasonality Score: 18 (-100 ... +100)